Multiple autoantibodies as predictors of Type 1 diabetes in a general population
At the initial screening, 55 children were ICA positive. These children were then tested for autoantibodies to insulin, GAD, IA-2 and IA-2β. Of the 55 children positive for ICA 13 also had antibodies to insulin, 18 to GAD, 13 to IA-2 and 8 to IA-2β (Fig. 1) . Of the 55 ICA-positive children, 11 progressed to Type 1 diabetes. Of these 11 ICA-positive children, 6 had autoantibodies to insulin, 10 to GAD, 9 to IA-2 and 7 to IA-2β. During the course of the study, only one ICA-negative child developed Type 1 diabetes. Table 1 shows the autoantibody profiles of the 11 ICA-positive children who developed Type 1 diabetes. All had multiple autoantibodies at the initial screening. Clinical disease developed 3 months to 10 years later. To the Editor: Autoantibodies have been widely used to predict the development of Type 1 diabetes [1] . Most studies have been carried out on first-degree relatives of Type 1 diabetic patients [2, 3, 4 ] who are at a 10 to 15-fold higher risk of developing the disease than people in the general population. However, approximately 85% of all patients who develop Type 1 diabetes do not have an affected family member.
To evaluate the predictive value of autoantibodies in a general population, we screened 9698 Florida school children, who were between 5 and 18 years of age, for islet-cell autoantibodies (ICA). Informed consent was obtained from all subjects under a protocol approved by the institutional review board at the University of Florida. We followed 3854 of these children for 6 to 12 years for the subsequent development of Type 1 diabetes. Letters
Of the 44 ICA-positive children who did not progress to diabetes, 36 had only ICA and none of the other autoantibodies. These children showed normal first-phase insulin release curves as evaluated by intravenous glucose tolerance tests. The remaining 8 ICA-positive children had at least one other autoantibody and showed abnormal first phase insulin release curves suggesting that they were at increased risk of eventually developing Type 1 diabetes.
Taken together with other reports [5, 6, 7, 8], our study shows that with ICA alone, the risk of developing Type 1 diabetes is low, whereas with more than one autoantibody the risk of developing Type 1 diabetes in a general school population is high. These findings on 3854 school children add further support to the concept that multiple autoantibodies are good predictive markers for Type 1 diabetes not only in first degree relatives, but also in a general population.
